Roberto Tirabosco

<i>IDH1</i> and <i>IDH2</i> mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours

Maria Fernanda Amary, Krisztián Bácsi, Francesca Maggiani et al. · The Journal of Pathology · 2011 · 994 citations · Full text

Medicine, Genetics, Oncology +16

A Mosaic Activating Mutation in <i>AKT1</i> Associated with the Proteus Syndrome

Marjorie J. Lindhurst, Julie C. Sapp, Jamie K. Teer et al. · New England Journal of Medicine · 2011 · 887 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone

Sam Behjati, Patrick Tarpey, Nadège Presneau et al. · Nature Genetics · 2013 · 853 citations · Full text

Medicine, Molecular Genetics, Oncology +9

<i>PAX3-FKHR</i> and <i>PAX7-FKHR</i> Gene Fusions Are Prognostic Indicators in Alveolar Rhabdomyosarcoma: A Report From the Children’s Oncology Group

Poul H. Sorensen, James C. Lynch, Stephen J. Qualman et al. · Journal of Clinical Oncology · 2002 · 741 citations

Medicine, Genetics, Oncology +17

Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas

Sonja Vujović, Stephen Henderson, Nadège Presneau et al. · The Journal of Pathology · 2006 · 589 citations

Life Sciences, Cancer Biology, Developmental Biology +6